Banks Pressure Health Care Firms To Raise Prices On Critical Drugs, Medical Supplies For Coronavirus
Investment bankers have been candid about the opportunity to raise drug prices on critical drugs and medical supplies

http://theintercept.com/2020/03/19/coronavirus-vaccine-medical-supplies-price-gouging/
Date Written:  2020-03-19
Publisher:  The Intercept
Year Published:  2020
Resource Type:  Article
Cx Number:  CX25147

In recent weeks, investment bankers have pressed health care companies on the front lines of fighting the novel coronavirus, including drug firms developing experimental treatments and medical supply firms, to consider ways that they can profit from the crisis.

Abstract: 
--

The media has mostly focused on individuals who have taken advantage of the market for now-scarce medical and hygiene supplies to hoard masks and hand sanitizer and resell them at higher prices. But the largest voices in the health care industry stand to gain from billions of dollars in emergency spending on the pandemic, as do the bankers and investors who invest in health care companies.

Subject Headings

• COVID-19
• Health Care Costs
• Health Care in the U.S.
• Health Care Industry
• Profit Motive
• Profitability Improvement